My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Roku Is Worth More As A Takeover Target — Her...
After SpaceX's Nearly $2 Trillion IPO, Is Bez...
Salesforce Puts Money Where Their Mouth Is -...
Micron's Broadcom‑Driven Drop Never Made Sens...
Kalshi's Record $18B Month Was Powered By A S...
SpaceX ETF Race Heats Up, Direxion Among Firs...
Anthropic Is Racing To Save Its Most Advanced...
Rivian Shares Advance As CEO Outlines Aggress...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    EMERGENT BIOSOLUTIONS INC (NYSE: EBS)

    Overview
    current price
    $8.29
    $8.29
    change
    -0.03 | -0.36%
    -0.03 | -0.36%
    Yesterday's Close
    8.32
    open
    8.46
    volume
    0.69 M
    30d. avg volume.
    0.80 M
    1 day
    8.23 - 8.49
    52 weeks
    5.62 - 14.06
    p/e
    0.00
    beta
    2.3288
    market cap
    0.43 B
    dividend yield
    0.00%
    Industry
    -
    EBS by TradingView
    News and Commentary
    Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals... Thursday, the FDA approved Emergent BioSolutions Inc.'s
    October 26 Market Summary Global investors on Wednesday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index dipped 0.47%, the British FTSE rose 0.61%, the German D...
    FDA Finds Deplorable Conditions after Johnson & Johnson Plant Inspection Last month, 15 million doses of vaccine had to be disposed of due to contamination during manufacturing. The U.S. Food and Drug Administration (FDA) now knows why after finding d...
    What Happened to 15 Million Doses of Johnson & Johnson's COVID Vaccine? The Biden administration has put Johnson & Johnson (
    Coronavirus Update: W.H.O. Warns Deaths Rates Expected to Rise Again, Novavax Joins Operation Warp S... The global first wave of the coronavirus pandemic is far from contained, with new case numbers in the epicenter of North, South and Central America increasing at a rapid rate com...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?